Personal medicine—the new banking crisis

As the healthcare industry moves from a twentieth century approach of providing treatments of last resort to a future of individualized medicine, biobanks will play a pivotal role in this transition. Yet at the cutting edge of biobanking research are new ethical, social and policy challenges beyond...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature biotechnology 2012-02, Vol.30 (2), p.141-147
Hauptverfasser:	Scott, Christopher Thomas, Caulfield, Timothy, Borgelt, Emily, Illes, Judy
Format:	Artikel
Sprache:	eng
Schlagworte:	631/114/129/2043 631/114/2401 631/61 Access control Agriculture Bioethics Bioinformatics Biomedical and Life Sciences Biomedical Engineering/Biotechnology Biomedical research Biomedicine Biotechnology Blood Specimen Collection - economics Blood Specimen Collection - trends Databases, Nucleic Acid - economics Databases, Nucleic Acid - trends DNA banks Ethical aspects feature Health care Humans Life Sciences Medical research Medicine, Experimental National Institutes of Health (U.S.) Personal health Political aspects Precision Medicine - economics Precision Medicine - trends Social aspects United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	As the healthcare industry moves from a twentieth century approach of providing treatments of last resort to a future of individualized medicine, biobanks will play a pivotal role in this transition. Yet at the cutting edge of biobanking research are new ethical, social and policy challenges beyond those familiar to basic biomedical research.
ISSN:	1087-0156 1546-1696
DOI:	10.1038/nbt.2116